The Cyprus Institute of Neurology & Genetics team intends to create a simple, convenient and low-cost prognosis kit about muscle wasting in Myotonic Dystrophy Type 1 (DM1). Since DM1 is an unpredictable disease in terms of the level of ambulatory status loss, independent living loss and lifelong assisted living, the scope is to identify and validate markers in the blood of patients with DM1 in order to predict the progression of the disease.